Peer Review History
| Original SubmissionJune 18, 2021 |
|---|
|
PONE-D-21-20112Spatial assessment of advanced stage diagnosis and lung cancer mortality in BrazilPLOS ONE Dear Dr. de Souza, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Edison I. O. Vidal, MD, MPH, PhD Section Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments/ Funding Section of your manuscript: This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001”. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 4. We note that Figures 1, 2, 3, 4, 5, S1 & S2 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figures 1, 2, 3, 4, 5, S1 & S2 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ Additional Editor Comments: I have read your manuscript with interest and have little to add to the several high-quality comments provided by several reviewers. Please notice that PLOS ONE requires authors to make all data necessary to replicate their findings publicly available. Please read carefully the PLOS policy on data availability (https://journals.plos.org/plosone/s/data-availability) since it is one of the criteria for publication in PLOS ONE. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a very well-written manuscript based on a carefully methodology related to spatial analysis, and the findings are very clearly presented. I have some comments about the manuscript that follow below: Methods: - Why the educational level was not used as an independent variable in the correlation analysis and multivariate model? It's an appropriate indicator of socioeconomic position. In the fourteen paragraph of the discussion section the authors stated that: "socioeconomic conditions, specially income and education, are crucial factors determining the lines and mortality of lung cancer". - About the Integrator of Hospital Cancer Records. What is the national coverage? Only lung cancer cases from public health services or covers cases from the private system? Are all units that receive cancer patients included in the integrator? - How the variables were grouped within the IRUA? By the average? Are the municipal boundaries coincident with the IRUA boundaries? - The authors used a bivariate correlation analysis. In the statistical analysis I suggest to add the information that Global Moran’s Index and the Local Indicator of Spatial Association (LISA) were employed to verify spatial correlation between the dependent and independent variables and its significant patterns. Results: - Figura 1 doesn't has scale and north symbol. - All figures have no scale. Discussion: - There is a limitation related to the fact that some lung cancer cases were not diagnosed being only registered on the death certificate. Thus, this incidence was not detected by the Integrator of Hospital Cancer Records. Reviewer #2: Comments for Plos One - Manuscript entitled 'Spatial assessment of advanced stage diagnosis and lung cancer mortality in Brazil' (PONE-D-21-20112) In their article, Lima et al provided relevant and innovative information regarding the spatial distribution of advanced-stage at diagnosis and mortality of lung cancer patients and its correlation with the offer of health services and socioeconomic indicators in Brazil. However, the manuscript has significant limitations that will be addressed below: Introduction 1. Information regarding lung cancer mortality in Brazil is not updated. More recent data are available at: <https: app="" mortalidade="" www.inca.gov.br="">. 2. The study reports that the 5-year survival rate for lung cancer around the world varies between 10 and 20% but do not give a reference for this information. I would like to suggest including data from this paper: Allemani et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. 3. I would like to suggest rewriting the paragraph beginning with 'In countries with a high Human Development Index (HDI), there are high incidence and mortality rates for lung cancer [1] and an elevated proportion of advanced-stage diagnosis – especially in low-income populations that live in regions with a lower supply of health services for primary prevention, diagnosis, and timely treatment [3,5] [...].' The information provided is not clear. Countries with high HDI normally do not include low-income countries as suggested in the text. Methods 4. The paper should include more information about definitions of the independent variables such as 'income' (per capita income?), 'health plan coverage' (private health insurance coverage?), 'density of diagnostic equipment' (what kind of equipment?), and density of specialist doctors (which specialists are included?). What is the difference between 'density of general practitioners' and 'density of family health teams'? In case they are different, is there collinearity between these two independent variables? 5. The study should explain briefly what is the 'Integrator of Hospital Cancer Records'. The paper should also include in the paragraph about limitations of the study, what kind of limitations this database presents (e.g., selection bias?, variation about the quality of information around the country?). 6. The ICD-10 codes C33-34 include 'malignant neoplasm of trachea, bronchus or lung' not only 'malignant neoplasms of lung' as reported in the paper. 7. The study should provide information about the numbers of cases (%) excluded (carcinoma in situ, cases not staged, and without information about place of residence and age). This information is essential because they give readers an idea about data quality. 8. I would like to suggest the revision of some acronyms included in the text as there is a correspondence in English for some of them (e.g. 'PNUD' - in English it is 'UNDP' and 'CID-10' - in English it is 'ICD-10') or there is a more comprehensible translation for a foreign reader such as 'National Regulatory Agency for Private Health Insurance and Plans' for 'ANS'. Results 9. The paper does not inform what the confidence level of the confidence intervals is (95%?). The same problem appears in the Abstract. 10. The abbreviation 'PASD' is used in some parts of the paper 'Proportion of Advanced-Stage Diagnosis'. I suggest not to use it as it is a non-standard abbreviation. Discussion 11. The first paragraph of this section needs to be rewritten in order to include the main findings of the paper. References 12. The references style must be reviewed. PLOS uses the reference style outlined by the International Committee of Medical Journal Editors (ICMJE), also referred to as the “Vancouver” style. Example formats are available at https://journals.plos.org/plosone/s/submission-guidelines#loc-references Figures 13. The quality of all figures (Fig 1-5) is flawed.</https:> Reviewer #3: This manuscript reports the relation between the proportion of advanced-stage diagnosis of lung cancer and some risk factors and, also, the relation between lung cancer mortality and some risk factors It was used Moran index to stablish the spatial autocorrelation of each variable and multivariable analysis to stablish the relation between variables. The statistical analysis is not clear in all cases and requires some clarification. The main finding is that there is a high proportion of advanced-stage diagnosis across the Brazilian territory and inequalities in lung cancer mortality, which are correlated with the most developed areas of the country. The study is of scientific interest but is confusingly presented. I have some questions and suggestions for improvement, as follows: Specific comments Abstract: * The author mentions many time the term correlation, however I suggest using the term association. Correlation is a specific statistical measure that normally not suggest any direction in the association. Which is not the case in this study, where author have a hypothesis of the direction of the association. * In the sentence ‘The proportion of advanced stage diagnosis was 85.28% (CI 83.3-87.1)’, it does not clear for me what are the denominator. Can the author please clarify? * In the sentence ‘The multivariate model for the mortality rates was constituted by the variables “Density of facilities licensed in oncology”, “Income”, and “Health plan coverage”.’ Not clear if this are all the variables used in the model or only the significant variables. Also, the author does not explain the objective in use this model. Can the author explain better of each analysis? Introduction * In the sentence ‘’Lung cancer staging at diagnosis and its associated mortality are determined by the histological type, socioeconomic conditions of the population, and the availability and quality of health services’. Is this true? Is the diagnosis established based on socioeconomic conditions? Better says that there is a relation or an association, but it seems to me that the diagnosis is not based on socioeconomic conditions of the population. * I would advise in sentence ‘’…and its correlation with socioeconomic indicators and health service offer.’ Replace correlation per association, already explained above. Methods * In the sentence ‘The dependent variables were the proportion…’ and ‘The independent variables were classified in socioeconomic indicators’, better call ‘response variables’ instead of ‘dependent variables’ and ‘explanatories variables’ instead of ‘The independent variables’. The use of the term ‘independent variables’ is not a very good option because what we are trying to find is variables that are not independent of the response variable. * In the sentence ‘For the correction of the number of deaths, the methodology proposed by Santos and Souza [12] was followed, considering redistribution per sex, age group, completeness of death record, and ill-defined deaths.’ Can the author please summarize this approach in methods? * In the sentence ‘Cases of carcinoma In Situ (TNM 0) and with no staging indication and residence were excluded.’ What mean TNM 0? Can the authors please clarify? * In the sentence ‘The crude and adjusted mortality rates (AMR) (per 100,000 inhabitants) were calculated for each IRUA according to the world population [… The 2013 population was employed as a reference and collected from the population estimate: municipality’. The authors adjusted the mortality rates according to the world population and why not adjusted the proportion of advanced-stage diagnosis of lung cancer? * In the sentence ‘the regions were classified as High-high and Low-low (when the area has surroundings with similar values) and High-low and Low-high (when the values of the surroundings are different).’ Can the authors please define how the reader can interpret the clusters High-high and Low-low? * In the sentence ‘Multivariate analysis of lung cancer mortality included only the independent variables that presented a statistically significant correlation with the dependent variable.’ Can the authors clarify how this statistically significant correlation was established? * In the sentence ‘The final model was selected based on the highest values of the likelihood logarithm, and lowest values for the Akaike Information Criterion (AIC) and Schwarz information criterion [20].’ The term ‘likelihood logarithm’ is not vary often used, we used ‘log-likelihood’. Please consider use this term. Also, it better to replace ‘and’ per ‘or’ because we cannot used the 3 at the same time, not always they going in the same direction. * In the sentence ‘The spatial autocorrelation of residues was assessed after defining the multivariate model, using Moran’s I and the data dispersion histogram.’ Are we using one model with all the variables into the models or are we using different models for each variable? Can the authors clarify? * Can the authors please clarify what was the multivariable regression models used? Results * In the sentence ‘Fig 1. (a) Spatial distribution and (b) spatial autocorrelation of proportion of advanced-stage diagnosis, combined per sex, of lung cancer; (c) spatial distribution and (d) spatial autocorrelation of adjusted mortality rates, for lung cancer, combined per sex, per IRUA, for 2011-2015.’ Please clarified what figures are for women or for men. * In the sentence ‘Spatial correlation between proportion of advanced-stage diagnosis of lung cancer and (a) Gini index, (b) aging rate, (c) income, and (d) urbanization degree, per IRUA, for 2011-2015.’ Moran Index is to stablish the spatial autocorrelation with a particular variable, so not sure how the author stablishes the spatial relation between two variables, e.g. advanced-stage diagnosis of lung vs Gini index. Can the author claritfy? * It seems that the authors in figure 2 analysis the data separately by sex, but in figure 3 it seems that authors put everything together * In the sentence ‘The residues presented normal distribution and Moran’s I was -0.04 (p<0.01)’, it seems that the variables included in the models do not explain all the variability of the data and residuals seems to presente some patterns. * In the sentence ‘However, due to theoretical plausibility and its capacity to adjust the final model, the variable “Licensed health facilities for cancer treatment” was preserved.’ I tis not very clear what was the process until the final model, and what was the final model. Can the author clarify? Discussion * No comments Reviewer #4: The article deals with a relevant problem for Public Health, in terms of magnitude and mortality – lung cancer. It uses spatial analysis techniques to explore ecological-level relationships between advanced-stage diagnosis and lung cancer mortality (treated as dependent variables in this study) and some socioeconomic indicators and others indicators related to the provision of health services. The units of analysis chosen were the Intermediate Regions of Urban Articulation in Brazil (IRUA). The authors use global and local spatial analysis methodologies as well as multivariate analysis to examine relationships of interest. The study is relevant, interesting and treats the literature in an adequate and coherent way. However, some points can be improved, and this review has as its main foundation a perspective of work improvement. The Complete Review was included in an attached document. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Adeylson Guimarães Ribeiro Reviewer #2: No Reviewer #3: No Reviewer #4: Yes: Alessandra Cristina Guedes Pellini [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-21-20112R1Spatial assessment of advanced stage diagnosis and lung cancer mortality in BrazilPLOS ONE Dear Dr. de Souza, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see my comments at the end of this email for additional comments. Please submit your revised manuscript by Jan 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Edison I.O. Vidal, MD, MPH, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: I commend the authors for the significant improvement related to the new version of their manuscript. However, there are still several issues that must be addressed before it can be reconsidered for publication, as described by the reviewers. In their first report on this manuscript, reviewer #3 argued that the authors had often misused the term “correlation” in their text. The reviewer claimed that correlation measures do not suggest any direction regarding the relationship between two variables. On the one hand, that explanation is incorrect because correlation coefficients measure the extent to which two variables have a linear relationship and may be positive or negative, thereby indicating the direction of that relationship. On the other hand, the authors responded to the reviewer’s comment by arguing that “The term association is used with qualitative variables. When variables are quantitative, as in the case of this study, the term correlation is the most appropriate. When testing the correlation, the coefficient generated quantifies the strength and direction of the relationship between two numerical variables, with results ranging from −1 to 1, which indicate a positive or negative correlation. Thus, when considering the type of variables included in the study, the term correlation is the most recommended.” Unfortunately, the authors’ argument also has several important flaws. First, it is incorrect to claim that the word “association” should be restricted to the relationship between qualitative variables. Although association and correlation are sometimes loosely used as synonyms, in statistics, correlation is more commonly used to refer to correlation coefficients, whereas association is a more generic term denoting a statistical dependence between two or more variables that may also be positive or negative. Moreover, correlation coefficients reflect the degree of linear association, i.e. the extent to which the points of the scatter plot of two variables are close to a monotonic line but say nothing about the slope of that line, which would be better described the coefficient of a linear regression equation. Hence, for the sake of clarity, I would like to recommend that the authors restrict the use of the term correlation to situations where they refer specifically to correlation coefficients or spatial autocorrelation measures and that they use the term association when referring to the coefficients derived from the equations of bivariate and “multivariate” spatial regression analyses throughout the text. By the way, “multivariable” regression is a more accurate term for the analyses performed in this study than “multivariate” regression. See the following article by Hidalgo and Goodman (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518362/) With regards to the association vs. correlation nomenclature, I recommend checking Miguel Porta’s Dictionary of Epidemiology (https://www.oxfordreference.com/view/10.1093/acref/9780199976720.001.0001/acref-9780199976720). As to the interpretation of correlation coefficients, I would like to suggest the following article by Patrick Schober (https://pubmed.ncbi.nlm.nih.gov/29481436/) [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: (No Response) Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All my comments have been addressed and I consider that the manuscript is suitable for publication in this version. Reviewer #2: Comments for Plos One - Manuscript entitled 'Spatial assessment of advanced stage diagnosis and lung cancer mortality in Brazil' (PONE-D-21-20112-R1) In their manuscript, Lima et al. provided relevant and innovative information regarding the spatial distribution of advanced stage at diagnosis and mortality of lung cancer patients and its correlation with the supply of healthcare services and socioeconomic indicators in Brazil. I consider that the new version (R1) of the manuscript improved considerably and all comments were addressed by authors. I have only some small comments regarding the manuscript: Authors´ affiliation 1. I think there is an error with the affiliation of the first author as in the manuscript appears two different Postgraduate Programs: 'Graduate Program in Collective Health' and 'Graduate Program in Public Health' belonging to the same Department (Public Health or Collective Health?). Abstract 2. I would like to suggest rewriting the sentence 'The adjusted mortality rates for lung cancer presented positive and statistically significant correlation with all the demographic and socioeconomic and health service offer indicators [...].' to 'The adjusted mortality rates for lung cancer presented a positive and statistically significant correlation with all demographic, socioeconomic and healthcare services supply indicators [...].' The term 'health service offer' appears many times in the manuscript, I would like to suggest considering using 'healthcare services supply' or 'supply of healthcare services'. 3. I would like to suggest to change the term 'Health plan coverage' to 'private health insurance coverage'. The authors sometimes also use the term 'Supplementary Health', I suggest unifying them. Introduction 4. I would like to suggest to chance the term 'advanced stage diagnosis' to 'advanced-stage diagnosis' or to 'advanced stage at diagnosis'. Materials and methods 5. Sometimes, the authors use the term 'Federation Units (FU)' other 'states'. Foreign people do not know if they are the same or not. Please, consider unifying them. The same problem happens to 'Integrator of Hospital Cancer Records'. Sometimes the authors use 'Integrator' other 'RHC' or 'IRHC' or 'RHC Integrator'. I suggest using the abbreviation 'Integrator-HBCRs' to the term 'Integrator of Hospital-Based Cancer Registries'. 6. Lung cancer is morphologically classified into different subtypes. Because of this, I suggest changing the term 'carcinoma in situ' to 'in situ disease'. 7. Please correct the spelling of 'non-colinear variables' to 'non-collinear variables'. Results 8. I would like to suggest changing the term 'lung cancer adjusted mortality rates' to 'age-adjusted mortality rates for lung cancer' or to 'age-adjusted lung cancer mortality rates'. Figure 1 9. I would like to suggest changing the term 'without staging' to 'stage not known'. 10. I would like to suggest changing the term 'carcinoma in situ' to 'in situ disease' or to 'not invasive cancer'. 11. Please, change the sentence '31,010 (73.2%) cases of lung cancer (age between 18 and 99 years were included)' to '31,010 (73.2%) cases of lung cancer (age between 18 and 99 years) were included'. S2 Fig 12. Include in the title the term 'Brazil'. S3 Fig 13. Include in the title the term 'Brazil'. Further, include the information about the meaning of x-axis and y-axis. Table 1 14. Include in the footnote the meaning of the abbreviations used in the table 15. I would like the confirmation of the authors if the description they used for the variable 'adjusted mortality rates for lung cancer' is correct: 'Lung cancer mortality rate, combined for men and women, adjusted for age and standard world population'. Reviewer #3: In relation to the topic 'correlation' and its use, I was not referring to the measure that varies between -1 and 1 and which is a correlation. The author appears to be using the term correlation when it is a measure of correlation and when it is not. For example, in the title of Figure 2, 'Spatial regression analysis of adjusted lung cancer mortality rates and their correlation with socioeconomic indicators and health service provision, by IRUA, 2011-2015', the author used the term correlation for the coefficients estimated by the regression model, this measure does not vary between -1 and 1, and it is not a correlation. It is more appropriate to use the term association between adjusted mortality and socioeconomic indicator rather than correlation. Can the author please review? Reviewer #4: The manuscript showed substantial improvement after the first review; however, I noticed that some aspects can still be improved. The new suggestions that I present, although they are relevant in number, are easy to resolve. 1. Figures: � Fig. 1: change the acronym “RHC”, which is in Portuguese, for “HCR” (Hospital Cancer Records). � S1 table: fix the name of the “spatial lag” model (this is described as “spatial log”). 2. Abstract: � Standardize the number of decimal places. For example: in lines 40 and 41 of the Abstract: “The proportion of advanced-stage diagnosis was 85.28% (95% CI 83.3-87.1).” – The proportion value (85.28%) appears with two places, and the 95% confidence interval with only one (95% CI 83.3-87.1). Standardize (I suggest keeping everything to two decimal places, then getting the CI values right). Also check this in the rest of the text. � Line 43: replace “Gini” by “Gini Index”. � Line 45: replace “significant correlation” by “significant spatial correlation”. � Lines 48 and 52 differ in the denomination of the variable related to Oncology Services – in line 48, it is described as “Density of licensed facilities in oncology”, and in line 52, “Density of Licensed Oncology Health Facilities”. Standardize the term, as well as the rest of the text. � Lines 51-53: replace the sentence: “The variable Density of Licensed Oncology Health Facilities presented positive correlation with the studied outcome, although without statistical significance.” by: “The variable Density of Licensed Oncology Health Facilities showed no significant correlation with lung cancer mortality rate”. 3. Introduction: � Line 62: the term “neoplasm” still appears in the text. Change the term “neoplasms” to “cancers” (including in reference [1] – GLOBOCAN, it is described as “cancers” and not “neoplasms”). � Lines 64-66: “In Brazil, in 2019, there were 16,661 deaths due to lung cancer in men and 12,593 deaths in women, which correspond to an estimated risk of 16.19/100,000 men and 9,84/100,000 women [2]”. First the author presents the numbers of deaths, then he says that this corresponds to estimates of risks (incidences). Review if the data really correspond to the incidence, in this case, do not use the term “which correspond”, but treat the two sentences as independent. Another option would be to present the number of new cancer cases of each sex, and then correlate the respective risks. � Lines 83-84: replace the phrase: “When considering the socioeconomic and distribution differences of health services in Brazilian regions” by: “When considering socioeconomic differences, as well as the distribution of health services in Brazilian regions”. 4. Material and Methods: � I suggest changing the name of the Subsection: “Study design” to “Study design and Spatial analysis units”, since the authors describe, in this item, several aspects related to the analysis units chosen for the study – IRUA. � In the subsection: “Study variables and data sources”, I suggest changing the order of the paragraphs, initially describing everything that refers to the response variables and, later, everything that concerns the exploratory variables. So, the new order would be: � Paragraph #1: “The response variables were the proportion of late-stage diagnosis and adjusted mortality rates ...” � Paragraph #2: “All data included here were collected by municipality and then aggregated to an IRUA territory level by means of averaging ...” � Paragraph #3: “Based on the TNM Classification of malignant tumors, lung cancer cases were classified as advanced stage (TNM III and IV) and early stage (TNM I and II) ...” � Paragraph #4: “The deaths that occurred in Brazil between 2011 and 2015 due to lung câncer (ICD-10, C33-34) [16] were collected from the Mortality Information System (MIS) ...” � Paragraph #5: “For the correction of the number of deaths, the methodology proposed by Santos and Souza [18] was followed ...” � Paragraph #6: “The crude and adjusted mortality rates (AMR) (per 100,000 inhabitants) were calculated for each IRUA ...” � Paragraph #7: “The explanatory variables were classified into demographic and socioeconomic indicators ...” � Paragraph #8: “Demographic and socioeconomic variables for 2010 were obtained from the Brazilian Atlas of Human Development (UNDP) ...” At the end of this last paragraph, keep the sentence already in lines 162-163: “Table 1 presents the study variables and corresponding descriptions ...” � Below the paragraphs of this Subsection, would then come Fig 1 (Flowchart) and Table 1 (Response and exploratory variables). � Line 118: describe the term “lung cancer” in italics. � Lines 122 and 125: change the acronym “RHC”, which is in Portuguese, to “HCR” (Hospital Cancer Records). � Line 129: replace the term “for 2011-2015” by “for each year”, as the way it is is repeated in relation to line 127, where the years were already mentioned. � Line 130: replace the term “residence” by “residence address”. � Lines 131 and 133: the excerpt “For the correction of the number of deaths” was repeated. I believe it can be deleted from line 133. � Line 135: does the word “state” mean “Federated Unit”? If so, it would be better to substitute by this last term. � Lines 135 and 138: replace the acronym “SIM” by “MIS” (as defined this acronym in line 128). � Line 146: the acronym UNPD refers to the Organ: “United Nations Development Programme”, which needs to be properly described in full. � Lines 147 and 148: the abbreviations “CNES” and “ANS” are in Portuguese; check the possibility of translating them into English, as was done for most acronyms in the text. � Line 154: replace “case selection” by “cases selection”. � Line 156 (title of Fig 1): change the acronym “RHC”, which is in Portuguese, to “HCR” (Hospital Cancer Records). � Table 1: � Replace “IRHC” with “IHCR” (Source of the second response variable). � Description of first variable: replace “and standard world population” by “based on standard world population”. � Replace “Explanatory (Contextual)” by “Explanatory Variables (Contextual)”. � In the descriptions of the explanatory variables, for some variables it is described that the population is from the year 2013, and for others it is not. Standardize. � In the description of the variable “Density of family health teams” the term “multiplied by” appears twice. � Consider revising the acronyms “CNES” and “ANS”, if they are changed in the rest of the text. � Line 176: replace “auto-correlation” with “autocorrelation” (no hyphen). � Lines 187-188: rewrite the sentence: “The validation of Moran’s I was carried out by a random permutation test, with 99 permutations” by: “The statistical significance of Moran's I was verified by a random permutation test, with 99 permutations”. � Lines 199-201: replace the phrase: “The multivariate analysis of lung cancer mortality included the explanatory variables that showed a statistically significant correlation with the response variable and non-colinear variables (correlation<0.7).” by: “The multivariate analysis of lung cancer mortality included explanatory variables that showed a statistically significant correlation with the response variable and that were not collinear with each other (correlation < 0.7).” � Line 201: replace “log” with “lag”. The model is called “spatial lag” (not “log”). � Lines 199-205: the authors explain how the multivariate analyzes were performed. In the first review, I had asked “why was multiple analysis done only for mortality, but not for the proportion of lung cancer cases with advanced diagnosis?” - and the authors replied: “The moderate spatial dependence of the proportion of diagnoses in advanced stage of lung cancer (Moran’s I = 0.37) and the weak correlations with the explanatory variables studied (as seen in figures 3 and 4) made it impossible to design a multiple analysis model.” I consider this information relevant to include in the text, perhaps in the limitations item, at the end of the discussion. 5. Results: � Lines 215 and 217: standardize two decimal places in the 95% CI values. � Line 227: replace “19.3%” with “19.36%” (two decimal places). � Lines 230-231: change sentence: “For the combined AMR for men and women, the average was 12.82 (SD 5.12) deaths per 100,000 inhabitants.” by: “The combined AMR for men and women was 12.82 (SD 5.12) deaths per 100,000 population.” (I believe the authors did not average the rates for men and women, which would be wrong, but instead calculated the rate for the entire population of men and women evaluated). � Line 231: where a new sentence starts - “The Itaberaba and Bom Jesus da Lapa ...” – break into another paragraph. � Line 236: “A spatial autocorrelation was observed (Moran’s I 0.50, p=0.01) with the formation ...”– does this autocorrelation refer to AMR? If so, consider rewriting: “AMR presented significative spatial autocorrelation (Moran’s I 0.50, p=0.01); with the formation ...” � Line 255: replace “Figure 4” with “Fig 4”, to keep the same pattern as the titles of the other figures. � Line 259: replace “correlation” with “spatial correlation”. � Lines 260-262: “All correlations are statistically significant, except for correlation with “density of family health teams” (Moran’s I -0.02 p=0.28)” - consider switching to: “All correlations were statistically significant, except for the variable “density of family health teams” (Moran’s I -0.02 p = 0.28)”. � Line 273: change “66%” to “66.3%” and reference Table 2. � Line 275: the variable name – “density of facilities licensed in oncology” is different from the nomenclature of the same variable in Table 2: “Density of Licensed Oncology Health Facilities”. Standardize this nomenclature throughout the text. � Lines 287-289: review the sentence: “The variable Density of Licensed Oncology Health Facilities showed a positive correlation with the studied outcome, although without statistical significance.” to: “The variable Density of Licensed Oncology Health Facilities showed no significant correlation with lung cancer mortality rate”. 6. Discussion: � Line 349: “In Forrest et al. [6]...” – change to: “In Forrest et al. study [6]..." � Line 351: exchange “inequalities social...” – by “social inequalities...” � Line 405: instead of “mainly in territories of Rio Grande do Sul”, change to “mainly in the Rio Grande do Sul state”. � In the first review, I presented some considerations about some divergent results, related to the coverage of health plans and oncology services, comparing the results obtained through the different analysis techniques used. The authors responded brilliantly in the document to the reviewer; therefore, I strongly recommend that such considerations be added, albeit briefly, to the text of the article's discussion. Are they: � Bivariate analysis showed a positive correlation between indicators of health insurance coverage and density of facilities licensed in oncology and the response variable adjusted mortality rates for lung cancer). But it was possible to see, through the maps, that there are clusters of high mortality in regions with low coverage of health plans, especially in IRUAs in the South region. � In the regression model, the density of facilities licensed in oncology lost significance and the coverage of health plans showed an inverse correlation with lung cancer mortality. This discrepancy in results may be related to the levels of socioeconomic inequalities that exist even in the most developed regions, as discussed in the text. This makes access to public or private health services unequal among populations. � Changes in address, in search of treatment, can also move part of the population with higher income to other regions with other health services, including private ones. Likewise, people who need access to health services through the SUS can migrate to places with a greater offer of public services. Both situations can contribute to the reduction of health plan coverage in regions with high mortality rates. � Lines 424-432: regarding this paragraph on the quality of health services, which cites the study by Kaliks et al., I suggest that the authors rewrite the paragraph incorporating their explanation in the document for reviewers, as follows: � The study was carried out with 52 cancer centers linked to the Unified Health System (SUS). The data referring to the treatment were compared to what is recommended by the Ministry of Health, through the Diagnosis and Treatment Guidelines, and to the standard practiced in supplementary health, based on the Procedures List of the National Health Agency (ANS). � Line 431: specify what the abbreviation “SS” means in full. � Line 459: replace the term “can help” by “could help”. � Line 460: replace the term “could have” by “may have”. 7. Conclusions: � Lines 467-469: rewrite the sentence: “The proportion of advanced-stage diagnosis was weakly spatially correlated to socioeconomic and demographics indicators only.” by: “The proportion of advanced-stage diagnoses was weakly spatially correlated only with socioeconomic and demographic indicators.” � Line 471: change the term: “independent of the offer” by “regardless the offer”. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Adeylson Guimarães Ribeiro Reviewer #2: No Reviewer #3: No Reviewer #4: Yes: Alessandra Cristina Guedes Pellini [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Spatial assessment of advanced-stage diagnosis and lung cancer mortality in Brazil PONE-D-21-20112R2 Dear Dr. de Souza, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Edison I.O. Vidal, MD, MPH, PhD Section Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-20112R2 Spatial assessment of advanced-stage diagnosis and lung cancer mortality in Brazil Dear Dr. de Souza: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Edison I.O. Vidal Section Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .